early HR+/HER2- Breast Cancer (DBCOND0169540)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Ribociclib A cyclin-dependent kinase inhibitor used to treat HR+, HER2- breast cancer.- Cyclin-dependent kinase 4target
- Cyclin-dependent kinase 6target
- Cytochrome P450 3A4enzyme
- Clinical Trials
- Not Available